Advertisement

‘Deltacron’ Variant Rare and Not a Major Concern

0

Hybrid is extremely rare and has not yet shown the ability to spread exponentially

New Malaria Treatment Gets First Approval for Use in Children

0

Single dose of tafenoquine is for use in combination with the traditional malaria drug chloroquine

Excess Mortality Adds to the Toll of the COVID-19 Pandemic

0

Between Jan. 1, 2020, and Dec. 31, 2021, 18.2 million people were estimated to have died worldwide due to the COVID-19 pandemic

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...

Black Patients Still Underrepresented in Trials for New Drug Approvals

0

No improvement seen in representation of Black patients after implementation of a 2015 FDA action plan to improve diversity

Masks Reduced COVID-19 Incidence in K-12 Setting in Arkansas

0

Districts in Arkansas with full mask requirements had 23 percent lower COVID-19 incidence among students, staff

Risk for Blood Clots After COVID-19 Vaccination Explored

0

Two studies show increase in intracranial venous thrombosis, thrombocytopenia for those younger than 70 years and in CVST after ChAdOx1-S

HPV-Associated Cancer Incidence Starting to Increase

0

Cervical cancer incidence plateaued in highest-income counties, increased in lowest-income counties in recent years

Secondary Transmission of SARS-CoV-2 Low in Cohort of K-12 Schools

0

Districts with optional masking had 3.6 times the rate of secondary transmission compared with universally masked districts

Pfizer Begins Trial of COVID-19 Drug Paxlovid in Children 6 to 17 Years

0

Trial will assess safety and efficacy in children with confirmed infection who are not hospitalized but are at risk for severe disease